Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Photofrin 75mg powder for solution for injection vials
0801050AHBBABAB
|
Photofrin | Porfimer sodium | Malignant Disease and Immunosuppression | No data available |
|
Phyllocontin Paediatric Continus 100mg tablets
0301030C0BCACAD
|
Phyllocontin | Aminophylline hydrate | Respiratory System | No data available |
|
Physeptone 20mg/2ml solution for injection ampoules
0407020M0BBACA3
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 35mg/3.5ml solution for injection ampoules
0407020M0BBADAT
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 50mg/2ml solution for injection ampoules
0407020M0BBAHA6
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 50mg/5ml solution for injection ampoules
0407020M0BBAEAN
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physiotens 200microgram tablets (Actavis)
0205020M0BBADAA
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
|
Physiotens 300microgram tablets (Actavis)
0205020M0BBAFAC
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
|
Physiotens 400microgram tablets (Actavis)
0205020M0BBAEAB
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
|
Phytex paint
1310020V0BCAAAB
|
Phytex | Salicylic acid | Skin | No data available |
|
Phytomenadione 10mg/5ml oral suspension
0906060Q0AAAPAP
|
Phytomenadione | Phytomenadione | Nutrition and Blood | No data available |
|
Phytomenadione 1mg/0.5ml solution for injection ampoules
0906060Q0AAAAAA
|
Phytomenadione | Phytomenadione | Nutrition and Blood | No data available |
|
Picato 150micrograms/g gel
1308010Z0BBAAAA
|
Picato | Ingenol mebutate | Skin | No data available |
|
Picato 500micrograms/g gel
1308010Z0BBABAB
|
Picato | Ingenol mebutate | Skin | No data available |
|
Pickles 0.15% antiseptic cream
1310050K0BCAAAA
|
Pickles Antiseptic | Dibrompropamidine isetionate | Skin | No data available |
|
Pickles Chilblain 1% cream
1314000M0BBAAAA
|
Pickles Chilblain | Methyl nicotinate | Skin | No data available |
|
Pickles Colsor lotion
131003000BLBEA0
|
Proprietary compound preparation BNF 1310030 | Other antiviral preparations | Skin | No data available |
|
Pico dressing kit 10cm x 20cm
20032100066
|
Pico dressing kit 10cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pico dressing kit 10cm x 30cm
20032100061
|
Pico dressing kit 10cm x 30cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pico dressing kit 10cm x 40cm
20032100079
|
Pico dressing kit 10cm x 40cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pico dressing kit 15cm x 15cm
20032100062
|
Pico dressing kit 15cm x 15cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pico dressing kit 15cm x 20cm
20032100063
|
Pico dressing kit 15cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pico dressing kit 15cm x 30cm
20032100080
|
Pico dressing kit 15cm x 30cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pico dressing kit 20cm x 20cm
20032100081
|
Pico dressing kit 20cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Pico dressing kit 25cm x 25cm
20032100082
|
Pico dressing kit 25cm x 25cm | Wound Management & Other Dressings | Dressings | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.